Sign in

Jill Andersen, J.D.

Chief Legal Officer and Corporate Secretary at Invivyd
Since November 2021
Age
52 years
Education
Earned a B.S. in Finance from Boston College and a J.D. from Wake Forest University School of Law.
Tenure
Joined IVVD in November 2021 as Chief Legal Officer and Corporate Secretary, and has been serving in that role continuously.

Also at Invivyd

About

Jill Andersen, J.D. is an experienced legal professional with a strong academic foundation, having earned her B.S. in Finance from Boston College and her J.D. from Wake Forest University School of Law.

Her career began in public service as an Assistant United States Attorney for the District of New Jersey from 2003 to 2007, after which she built a notable trajectory in the pharmaceutical and biotechnology industries through leadership roles at organizations such as Novartis, Celgene, and Oyster Point Pharma.

Since November 2021, she has served as Chief Legal Officer and Corporate Secretary at IVVD, where she is dedicated to corporate governance, regulatory compliance, and legal strategy. Her extensive experience and consistent commitment to legal excellence have been instrumental in guiding the company’s legal and compliance functions.

Past Roles

OrganizationRoleDate RangeDetails
Oyster Point Pharma, Inc. General Counsel, Corporate Secretary, and Chief Compliance Officer June 2020 – October 2021 Held a legal and compliance leadership role
Bristol-Myers Squibb Company Vice President, Legal November 2019 – May 2020 Role commenced after the acquisition of Celgene Corporation
Celgene Corporation Vice President and Head of Legal, Inflammation & Immunology Franchise, U.S. Market Access and Contracts September 2016 – November 2019
Novartis Services, Inc. Vice President and General Counsel, Legal & Intellectual Property Global Assets March 2015 – September 2016
Novartis Consumer Health U.S. General Counsel and Compliance Officer February 2014 – March 2015
Novartis Pharmaceuticals Corporation Various roles of increasing responsibility 2007 – March 2015
Assistant United States Attorney Assistant United States Attorney for the District of New Jersey 2003 – 2007

Fixed Compensation

Data from  FY 2023
Component NameAmountPayment ScheduleAdditional Details
Base Salary $460,000 Annual Determined and approved by the Compensation Committee
Equity Awards $1,151,338 Grant date-based Aggregate grant date fair value of option awards measured under FASB ASC Topic 718
All Other Compensation $11,680 Annual Includes employer 401(k) contributions and life insurance premiums

Performance Compensation

Data from  FY 2023

Annual Performance Bonus

MetricValueAdditional Details
Target Bonus Percentage40% of annual base salary Based on company corporate goals
Attainment Multiplier200% if the Specified Milestone is achieved Milestone achievement determined by the Board
Payout Amount$368,000 Paid as cash under Non-Equity Incentive Plan Compensation

Cash-Based Incentive Program

MetricValueAdditional Details
MilestoneDosing first participant in a pivotal clinical trial of VYD222 by September 30, 2023 Milestone achieved in September 2023 during the CANOPY Phase 3 trial
Payout Amount$92,000 Calculated as a percentage of the annual bonus target
Vesting/Grant DetailsNot applicableCash-based payout; no vesting schedule, grant date, fair value, or stock price